Ebola Test Vaccines Produce Year-Long Immune Response in Most Study Participants

[FrontPageAfrica] Monrovia -Results from PREVAIL I–a large Ebola vaccine study that enrolled more than a thousand Liberians at Redemption Hospital in Monrovia during the first few months of 2015– have been published in the October 12th issue of The N…

[FrontPageAfrica] Monrovia -Results from PREVAIL I--a large Ebola vaccine study that enrolled more than a thousand Liberians at Redemption Hospital in Monrovia during the first few months of 2015-- have been published in the October 12th issue of The New England Journal of Medicine. The results show that the two test vaccines, cAd3-EBOZ and rVSV-ZEBOV, pose no major safety concerns and can produce immune responses within one month after vaccination that last for at least one year.

source: AllAfrica News: Liberia